SANOFI SYNTHELABO SA 13D and 13G filings for Inhibrx Biosciences, Inc.:
- Schedule 13D must be filed within ten days after a person or an organization acquires beneficial ownership of more than 5% of a voting class of a company's equity securities.
- Shares have been adjusted for stock splits.
| Reported DateTime |
Transaction Date |
Type | Company Symbol |
Filed By Symbol |
Shares Owned % Owned |
Shares Vs. Prev Report | View |
| 2024-05-31 4:30 pm Purchase |
2024-05-30 | 13G | Inhibrx Biosciences, Inc. INBX |
SANOFI SYNTHELABO SA | 1,157,926 8.000% |
1,157,926 (New Position) |
Filing |